Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Choosing between SP 500 and multi-asset strategies depends on goals and risk comfort. This intro contrasts outcomes to guide retirement design.
26,826 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
As tariffs re-emerge under Section 301, policymakers push a framework that has endured decades of legal challenges. T...
Bitcoin nears new highs as Zcash and MemeCore lead a double-digit rally among smaller tokens, while Ethereum and XRP ...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
The CFTC unveiled an Innovation Task Force to steer policy on crypto, AI, and prediction markets. Regulators aim for ...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
Major acts are trimming or canceling large legs of US tours as fans face higher prices and travel costs. Industry wat...
OpenAI launches Daybreak to catch vulnerabilities before hackers exploit them, signaling a new era for crypto risk ma...
Block slashed more than 4,000 jobs in February 2026 and reported a sharp rise in first-quarter earnings, signaling a ...
Taiwan Semiconductor sits near $394 as Q1 2026 beat and AI demand boost growth; investors ponder whether to buy, sell...
Ford’s stock closed at its highest level in three years, powered by AI tie-ups, improving European margins, and robus...
SpaceX has secured a $2 billion Space Force contract to develop and sustain satellites. The award strengthens ties be...